Food/Recall·openFDA/food

The Coffee Connexion Co., Inc — Class I: Aramark Cheese Sauce New & Improved, 25 lb., packaged in a tied poly bag and packed 2 bags

HighPublished Jun 10, 2026· AI-analyzed Jun 15, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The Coffee Connexion Co., Inc has initiated a Class I recall for 'Aramark Cheese Sauce New & Improved' due to potential Salmonella contamination linked to a dry milk powder ingredient provided by a supplier.

Who it affects

This recall affects The Coffee Connexion Co., Inc, foodservice providers using Aramark brand cheese sauce, and quality assurance personnel responsible for ingredient supplier qualification.

Why it matters

A Class I designation indicates the FDA's assessment of a high risk for serious adverse health consequences or death. This situation highlights the critical regulatory risk of downstream contamination, where a raw material supplier's failure impacts the compliance status of the finished product manufacturer. Operations may need to review supplier verification programs to prevent similar issues with dehydrated dairy ingredients.

Practical takeaway

Quality teams should immediately verify if this specific UPC is in their inventory, isolate affected lots, and conduct a trace-back exercise to determine if this contaminated milk powder was utilized in other product formulations. Supply chain departments should evaluate the reliability of the third-party dry milk supplier mentioned in the source.

FDA source material

Class I. Reason: Product contains dry milk powder ingredient recalled by the supplier due to potential Salmonella contamination. Product: Aramark Cheese Sauce New & Improved, 25 lb., packaged in a tied poly bag and packed 2 bags per case, UPC 0039954925121. Firm: The Coffee Connexion Co., Inc (Lebanon TN United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.